Pharmacokinetics of loop diuretics in congestive heart failure.
作者信息
Brater D C
机构信息
Department of Medicine, Indiana University School of Medicine, Indianapolis.
出版信息
Br Heart J. 1994 Aug;72(2 Suppl):S40-3. doi: 10.1136/hrt.72.2_suppl.s40.
Abstract
摘要
相似文献
1
Pharmacokinetics of loop diuretics in congestive heart failure.袢利尿剂在充血性心力衰竭中的药代动力学
Br Heart J. 1994 Aug;72(2 Suppl):S40-3. doi: 10.1136/hrt.72.2_suppl.s40.
2
Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.托拉塞米在充血性心力衰竭中的药代动力学和药效学
Cardiology. 1994;84 Suppl 2:108-14. doi: 10.1159/000176463.
3
Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.托拉塞米和呋塞米在充血性心力衰竭患者中的生物利用度、药代动力学及药效学
Clin Pharmacol Ther. 1995 Jun;57(6):601-9. doi: 10.1016/0009-9236(95)90222-8.
4
Drug absorption in congestive heart failure: impact on management.充血性心力衰竭中的药物吸收：对治疗的影响。
Prog Cardiovasc Nurs. 1999 Winter;14(1):30-2.
5
Pharmacokinetics and pharmacodynamics of torasemide in health and disease.托拉塞米在健康与疾病状态下的药代动力学和药效学
J Cardiovasc Pharmacol. 1993;22 Suppl 3:S24-31. doi: 10.1097/00005344-199322003-00004.
6
The pharmacodynamics of torsemide in patients with congestive heart failure.托拉塞米在充血性心力衰竭患者中的药效学。
Clin Pharmacol Ther. 1994 Jul;56(1):48-54. doi: 10.1038/clpt.1994.100.
7
Pharmacokinetics of torsemide in patients with decompensated and compensated congestive heart failure.
J Clin Pharmacol. 1998 Aug;38(8):708-14. doi: 10.1002/j.1552-4604.1998.tb04810.x.
8
The use of diuretics in congestive heart failure.利尿剂在充血性心力衰竭中的应用。
Semin Nephrol. 1994 Sep;14(5):479-84.
9
Diuretic treatment for the sodium retention of congestive heart failure.利尿剂治疗充血性心力衰竭的钠潴留。
Arch Intern Med. 1994 Sep 12;154(17):1905-14.
10
Drug absorption in congestive heart failure: impact on management.充血性心力衰竭中的药物吸收：对治疗的影响。
Prog Cardiovasc Nurs. 1999 Spring;14(2):72-4.
引用本文的文献
1
Neurohormonal Effects of Intravenous Dopamine in Patients with Acute Heart Failure.静脉注射多巴胺对急性心力衰竭患者的神经激素影响。
J Clin Med. 2024 Sep 24;13(19):5667. doi: 10.3390/jcm13195667.
2
An Updated Review of the Management of Chronic Heart Failure in Patients with Chronic Kidney Disease.慢性肾脏病患者慢性心力衰竭管理的最新综述
Rev Cardiovasc Med. 2024 Apr 11;25(4):144. doi: 10.31083/j.rcm2504144. eCollection 2024 Apr.
3
Diuretic Combination Therapy in Acute Heart Failure: An Updated Review.利尿剂联合治疗急性心力衰竭：最新综述。
Curr Pharm Des. 2024;30(33):2597-2605. doi: 10.2174/0113816128316596240625110337.
4
Combination of diuretics for acute heart failure: a protocol for a systematic review of randomised clinical trials with network meta-analysis and trial sequential analysis.利尿剂联合治疗急性心力衰竭：一项基于网状 Meta 分析和序贯试验分析的随机临床试验系统评价方案。
BMJ Open. 2024 Apr 8;14(4):e081890. doi: 10.1136/bmjopen-2023-081890.
5
Diuretic Treatment in Patients with Heart Failure: Current Evidence and Future Directions - Part I: Loop Diuretics.心力衰竭患者的利尿剂治疗：当前证据和未来方向 - 第一部分：袢利尿剂。
Curr Heart Fail Rep. 2024 Apr;21(2):101-114. doi: 10.1007/s11897-024-00643-3. Epub 2024 Jan 19.
6
Diuretic Strategies in Acute Decompensated Heart Failure: A Narrative Review.急性失代偿性心力衰竭的利尿策略：一项叙述性综述
Can J Hosp Pharm. 2024 Jan 10;77(1):e3323. doi: 10.4212/cjhp.3323. eCollection 2024.
7
Urine sodium concentration after intravenous furosemide in dogs with acute congestive heart failure and correlation with treatment efficacy.犬急性充血性心力衰竭静脉注射呋塞米后排尿钠浓度与疗效的相关性。
J Vet Intern Med. 2024 Jan-Feb;38(1):71-80. doi: 10.1111/jvim.16955. Epub 2023 Dec 1.
8
The Prognostic Role of Spot Urinary Sodium and Chloride in a Cohort of Hospitalized Advanced Heart Failure Patients: A Pilot Study.即时尿钠和氯在一组住院晚期心力衰竭患者中的预后作用：一项初步研究。
Life (Basel). 2023 Mar 5;13(3):698. doi: 10.3390/life13030698.
9
Toward quantification of loop diuretic responsiveness for congestive heart failure.针对充血性心力衰竭的袢利尿剂反应性的定量评估。
J Vet Intern Med. 2023 Jan;37(1):12-21. doi: 10.1111/jvim.16590. Epub 2022 Nov 21.
10
Management of Acute Heart Failure during an Early Phase.急性心力衰竭早期阶段的管理
Int J Heart Fail. 2020 Apr 17;2(2):91-110. doi: 10.36628/ijhf.2019.0014. eCollection 2020 Apr.
本文引用的文献
1
Diuretic resistance: reduced bioavailability and effect of oral frusemide.利尿剂抵抗：口服速尿的生物利用度降低及效果
Br Med J. 1980 Jun 28;280(6231):1577. doi: 10.1136/bmj.280.6231.1577.
2
Furosemide in patients with heart failure: shift in dose-response curves.心力衰竭患者使用呋塞米：剂量反应曲线的变化
Clin Pharmacol Ther. 1980 Aug;28(2):182-6. doi: 10.1038/clpt.1980.148.
3
Absorption and disposition of furosemide in congestive heart failure.
Kidney Int. 1982 Aug;22(2):171-6. doi: 10.1038/ki.1982.149.
4
Diuretic potency of combined hydrochlorothiazide and furosemide therapy in patients with azotemia.氮质血症患者联合使用氢氯噻嗪和呋塞米治疗的利尿效力。
Am J Med. 1982 Jun;72(6):929-38. doi: 10.1016/0002-9343(82)90854-3.
5
Combined therapy with thiazide-type and loop diuretic agents for resistant sodium retention.噻嗪类利尿剂与襻利尿剂联合治疗顽固性钠潴留。
Ann Intern Med. 1983 Sep;99(3):405-6. doi: 10.7326/0003-4819-99-3-405.
6
Bumetanide and furosemide in heart failure.
Kidney Int. 1984 Aug;26(2):183-9. doi: 10.1038/ki.1984.153.
7
Furosemide absorption altered in decompensated congestive heart failure.呋塞米在失代偿性充血性心力衰竭中的吸收发生改变。
Ann Intern Med. 1985 Mar;102(3):314-8. doi: 10.7326/0003-4819-102-3-314.
8
Resistance to loop diuretics. Why it happens and what to do about it.对袢利尿剂的抵抗。其发生原因及应对措施。
Drugs. 1985 Nov;30(5):427-43. doi: 10.2165/00003495-198530050-00003.
9
Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.速尿在充血性心力衰竭中的稳态吸收动力学和药效学
Int J Clin Pharmacol Ther Toxicol. 1987 Mar;25(3):123-8.
10
Pharmacokinetic and pharmacodynamic interactions between furosemide and hydrochlorothiazide in nephrotic patients.
Nephron. 1988;49(3):223-7. doi: 10.1159/000185059.
Zotero 插件